Yahoo Web Search

Search results

1. • 

     Syrian first lady Asma al-Assad diagnosed with leukemia, president's office says

     Fox News via Yahoo News· 21 hours ago

     Asma al-Assad will “adhere to a specialized treatment protocol that includes stringent infection...

2. • Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas | JD Supra

     JD Supra· 5 days ago

     If you have been diagnosed with acute myeloid leukemia but cannot figure out why, benzene may be responsible. Benzene, a chemical used ...

3. • 

     Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research

     Local 12 Cincinnati· 6 days ago

     The local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...

4. • 

     Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com

     Investing.com· 7 days ago

     Aptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...

5. • MD Anderson Research Highlights for May 21, 2024 | Newswise

     Newswise· 1 day ago

     The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These

6. • Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...

     WTRF Wheeling· 6 days ago

     Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...

7. • 

     Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Hi

     Guru Focus· 6 days ago

     Net Loss: $3.2 million for Q1 2024, improved from $5.3 million in Q1 2023.Earnings Per Share (EPS):...

8. • Q2 2024 EPS Estimates for Syros Pharmaceuticals, Inc. Increased by HC Wainwright (NASDAQ:SYRS)

     ETF DAILY NEWS· 5 days ago

     Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) – Research analysts at HC Wainwright lifted their Q2 2024 EPS estimates for Syros Pharmaceuticals in a research report issued to clients ...

9. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 7 days ago

     PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with

10. • Q1 2024 Exscientia PLC Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 5 hours ago

      Today, we are providing updates for our highly differentiated LSD1 inhibitor the XS74539, or 539, which continues its progression towards a Phase 1 clinical trial in acute ...